SCHEMBL7207260

SCHEMBL7207260

COc1cc(C(O)c2ccccn2)c2cccc(C)c2n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
PDE10A Q9Y233 2/20 0.45
MAPT P10636 2/20 0.42
SCN8A Q9UQD0 1/20 0.37
PDPK1 O15530 1/20 0.36
AHR P35869 2/20 0.35
RAF1 P04049 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.35
ACHE P22303 1/20 0.34
BLM P54132 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
SCD O00767 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227661 0.85 CYP3A4 (0.44) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL7207277 0.84 MAPT (0.45) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL7225702 0.83 MAPT (0.46) CYP3A4PDE10AMAPTAHRALDH1A1
SCHEMBL7221174 0.83 MAPT (0.45) PDE10AMAPTPDPK1ALDH1A1KDM4E
SCHEMBL7219899 0.72 MAPT (0.42) CYP3A4MAPTPDPK1ALDH1A1KDM4E
SCHEMBL23610028 0.71 GAA (0.51) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL9771056 0.71 GAA (0.51) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL31143633 0.71 GAA (0.51) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL31143628 0.71 GAA (0.51) CYP3A4PDE10AMAPTSCN8AALDH1A1
SCHEMBL30392768 0.71 GAA (0.51) CYP3A4PDE10AMAPTSCN8AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608085-B1 Administering for neuroprotection VERNALIS RESEARCH LIMITED (GB) 2003-08-19 US disclosed
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107761-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (II) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013682-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS.(II) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed